CoChat

Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta‐Analysis

Zhang, Yujie, Zhang, Jingjing, Zhan, Yunfan, Pan, Zhe, Liu, Qiaohong, Yuan, Wei'an · 2024 · Journal of Cachexia, Sarcopenia and Muscle
Cited by 37

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: The relationship between sarcopenia and the prognosis of patients with tumours who received radio‐ and/or chemotherapy still needs to be determined. In this study, we aim to investigate the relationship between sarcopenia and adverse effects and mortality in patients with tumours that received radio‐ and/or chemotherapy, stratified by study design, tumour category, the method sarcopenia assessed, treatment options, study location and among other factors. Methods: PubMed, Web of Science and Embase were searched from inception to 15 August 2024, without language restrictions and with a manual search of references for additional articles retrieval. Cohort studies of ≥ 100 patients with tumours that evaluated the association between sarcopenia or muscle mass and the adverse effects or overall survival induced by radio‐ and/or chemotherapy were included. Results: Thirty‐nine studies were included, involving 8966 patients with tumours, including 3383 patients with sarcopenia. The pooled prevalence of sarcopenia in patients with tumours was 0.42 (95% CI 0.36–0.48, p < 0.001) overall. The prevalence of sarcopenia is higher in Oceania patients 0.60 (95% CI 0.28–0.89, p < 0.001), those with reproductive tumour 0.57 (95% CI 0.30–0.83, p < 0.001), and sarcopenia assessed by the lumbar‐skeletal muscle index 0.46 (95% CI 0.39–0.53, p < 0.001) than in other subgroups, but not show significant differences in sex. Sarcopenia was associated with an increased risk of adverse effects in patients who received radio‐ and/or chemotherapy, with a relative risk (RR) of 1.44 (95% CI 1.21–1.71, p < 0.001). Retrospective studies (RR = 1.49; 95% CI 1.24–1.79; p < 0.001), sarcopenia assessed by other methods (RR = 2.98; 95% CI 1.52–5.87; p < 0.001), and patients in Europe (RR = 1.92; 95% CI 1.15–3.22; p = 0.013), received chemoradiotherapy (RR = 1.47; 95% CI 1.23–1.76; p < 0.001), and with head and neck tumours (RR = 1.54; 95% CI 1.17–2.01; p = 0.010) had higher relative risk than other subgroups. Sarcopenia was also associated with reduced overall survival in patients with tumours, with a pooled hazard ratio (HR) of 1.66 (95% CI 1.40–1.96, p < 0.001). Prospective studies (HR = 1.72; 95% CI 0.97–3.07; p = 0.065), sarcopenia assessed by the cervical‐skeletal muscle index (HR = 2.66; 95% CI 1.73–4.09; p < 0.001), and patients in Asia (HR = 1.91; 95% CI 1.50–2.42; p < 0.001), received chemoradiotherapy (HR = 1.85; 95% CI 1.46–2.45; p < 0.001) and with head and neck tumours (HR = 2.35; 95% CI 1.88–2.95; p < 0.001) had higher HR than other subgroups. Conclusions: Sarcopenia was associated with a higher risk of adverse effects and mortality in patients with tumours received radio‐ and/or chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcsm.13629

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 75

  1. 10.1002/jcsm.12483 · DOI · Paper page
  2. 10.1093/ageing/afab148 · DOI
  3. 10.1093/ageing/afq034 · DOI · Paper page
  4. 10.1016/j.jamda.2013.11.025 · DOI · Paper page
  5. 10.1016/j.jamda.2011.01.003 · DOI · Paper page
  6. 10.1002/jcsm.12783 · DOI · Paper page
  7. 10.1016/S0047-6374(02)00196-3 · DOI · Paper page
  8. 10.1007/978-3-319-57379-3_19 · DOI · Paper page
  9. 10.1016/j.clnu.2017.07.010 · DOI · Paper page
  10. 10.1016/j.ejca.2008.02.033 · DOI · Paper page
  11. 10.1177/0884533616680354 · DOI · Paper page
  12. 10.1002/jcsm.13082 · DOI
  13. 10.1097/SLA.0000000000005452 · DOI
  14. 10.1002/jcsm.13126 · DOI
  15. 10.1002/jcsm.12468 · DOI · Paper page
  16. 10.3390/ijms20102428 · DOI · Paper page
  17. 10.3390/ijms21010119 · DOI
  18. 10.1038/nrclinonc.2012.209 · DOI · Paper page
  19. 10.1016/j.ejca.2008.10.031 · DOI
  20. 10.1001/jama.283.15.2008 · DOI · Paper page
  21. 10.1007/s10654-010-9491-z · DOI · Paper page
  22. 10.1136/bmj.327.7414.557 · DOI · Paper page
  23. Irwig L., 1998, Bias in Meta‐Analysis Detected by a Simple, Graphical Test. Graphical Test Is Itself Biased, BMJ., 316, 470
  24. 10.1007/s10147-021-02062-z · DOI
  25. 10.1017/S0007114522000435 · DOI
  26. 10.1002/jso.27251 · DOI
  27. 10.1080/0284186X.2021.1983210 · DOI
  28. 10.1186/s12885-019-5319-8 · DOI
  29. 10.3389/fonc.2018.00457 · DOI
  30. 10.1002/jcsm.12234 · DOI · Paper page
  31. 10.1002/jcsm.12267 · DOI · Paper page
  32. 10.1016/j.radonc.2019.04.023 · DOI
  33. 10.1002/jcsm.12115 · DOI
  34. 10.1177/1758835920947612 · DOI
  35. 10.1002/cam4.2538 · DOI
  36. 10.21873/anticanres.14060 · DOI
  37. 10.3390/jpm11090936 · DOI
  38. 10.2169/internalmedicine.0900-22 · DOI
  39. 10.1080/01635581.2020.1870704 · DOI
  40. 10.1002/jcsm.13462 · DOI
  41. 10.3389/fonc.2024.1378762 · DOI
  42. 10.1158/1078-0432.CCR-18-0788 · DOI
  43. 10.1002/lary.29221 · DOI
  44. Li J. H., 2023, Relationships of Body Composition and Adipocytokines With Outcomes in Metastatic Castration‐Resistant Prostate Cancer Patients Receiving Docetaxel Chemotherapy, Asian Journal of Andrology., 25, 520
  45. 10.1007/s11604-024-01587-3 · DOI
  46. 10.1002/cam4.3604 · DOI
  47. 10.3389/fonc.2020.01576 · DOI
  48. 10.3390/nu14214448 · DOI
  49. 10.1016/j.radonc.2023.109764 · DOI
  50. 10.1186/s13014-021-01876-5 · DOI · Paper page
  51. 10.1186/s12876-022-02296-9 · DOI
  52. 10.1038/s41391-019-0186-6 · DOI
  53. 10.1371/journal.pone.0195406 · DOI
  54. 10.3390/cancers13040753 · DOI
  55. 10.1093/icvts/ivad020 · DOI
  56. 10.1002/jcsm.12487 · DOI
  57. 10.3389/fonc.2021.655071 · DOI
  58. 10.1016/j.anl.2021.03.021 · DOI
  59. 10.1016/j.radonc.2020.07.043 · DOI
  60. 10.1016/j.nut.2020.111135 · DOI
  61. 10.1080/17512433.2017.1347503 · DOI
  62. 10.1111/obr.12254 · DOI · Paper page
  63. 10.1002/jcsm.12168 · DOI
  64. 10.1002/jcsm.12235 · DOI
  65. 10.1186/s13395-019-0209-y · DOI
  66. 10.1158/1078-0432.CCR-08-2242 · DOI · Paper page
  67. 10.1158/1078-0432.CCR-16-2266 · DOI · Paper page
  68. 10.1093/annonc/mdx271 · DOI · Paper page
  69. 10.1038/s41598-022-27238-z · DOI
  70. 10.1016/j.clnesp.2022.04.009 · DOI
  71. 10.1007/s10549-019-05352-3 · DOI
  72. 10.1080/01635581.2022.2077387 · DOI
  73. 10.1016/j.ejso.2019.03.003 · DOI
  74. 10.1097/SLA.0000000000002679 · DOI · Paper page
  75. 10.3390/cancers14030785 · DOI

Metadata

Authors
Zhang, Y., Zhang, J., Zhan, Y., Pan, Z., Liu, Q., & Yuan, W.
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2024-11-11
Volume
15
Issue
6
Pages
2295-2310
ISSN
  • 2190-5991
  • 2190-6009
Cited by
37
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.